title: Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
authors: Osaka University, Osaka, Japan. ttanak@imed3.med.osaka-u.ac.jp
authors: Toshio
authors: T
authors: Tanaka
authors: Yusuke
authors: Y
authors: Kuwahara
authors: Yoshihito
authors: Y
authors: Shima
authors: Toru
authors: T
authors: Hirano
authors: Mari
authors: M
authors: Kawai
authors: Masako
authors: M
authors: Ogawa
authors: Junsuke
authors: J
authors: Arimitsu
authors: Keisuke
authors: K
authors: Hagihara
authors: Masashi
authors: M
authors: Narazaki
authors: Atsushi
authors: A
authors: Ogata
authors: Ichiro
authors: I
authors: Kawase
authors: Tadamitsu
authors: T
authors: Kishimoto
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D016918:Arthritis, Reactive / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D002951:Citrates; D005260:Female; D005708:Gallium; D006304:Health Status; D006801:Humans; D007596:Joints / Q000187:drug effects / Q000503:physiopathology; D011877:Radionuclide Imaging; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors* / Q000276:immunology; D012720:Severity of Illness Index; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D002951:Citrates; D019947:Receptors, Interleukin-6; D005708:Gallium; C103850:gallium citrate; C502936:tocilizumab